India to Gambia Pharmaceutical Export (2026) — $8.5M, 58 Suppliers | TransData Nexus

India to Gambia Pharmaceutical Export (2026) — $8.5M, 58 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Gambia

#	Formulation	Value	Share
1	Crp Test Kit	$386.7K	4.6%
2	Dolutegravir(as Sodium)/lamivudine/tenofovir Disoproxil Fumaratetabletsa#a#a# 5…	$317.0K	3.7%
3	Harmless Medicines:amodiaquine 150mg +sulfadoxine/pyrimethamine 500/25mg Disper…	$152.3K	1.8%
4	Hba1c Test Kit	$85.8K	1.0%
5	Dolutegravir (as Sodium)+lamivudine+tenofovir Disoproxil Fumarate Tablets 50/30…	$79.9K	0.9%
6	Harmless Medicines for Human Consumption, Product Code No.5696 ((each Uncoated…	$73.8K	0.9%
7	Harmless Medicines for Human Consumptio	$70.9K	0.8%
8	Cortim Tablets (new Artwork) (each Uncoated Tablet Cont.trimethoprim BP 80 Mg,s…	$70.0K	0.8%
9	Dyclosa 50 Tablets (new Artwork) ( Each	$68.6K	0.8%
10	Reality Extra Tablet (paracetamol BP 325mg, Diclofenac Sodium BP 50 Mg, Caffein…	$64.6K	0.8%
11	Killpane Tablets(acetylsalicylic Acid 300mg+ Paracetamol 150mg + Caffeine 30 Mg…	$64.5K	0.8%
12	Harmless Medicines for Human Consumption ( Batch No: Kt4391,kt4392), Kt4569,kt4…	$57.7K	0.7%
13	Super Peptee Tablets Cyproheptadine Tablets B P 4mg Batch No T01 T04 Mfg Dt 02…	$54.9K	0.6%
14	Dexamethasone Tablets BP 0.5 Mgnos	$53.9K	0.6%
15	Harmless Medicines for Human Consumption (batch No:kt4015kt4016kt4017kt4018kt40…	$50.1K	0.6%

India exports 18+ pharmaceutical formulations to Gambia with a combined trade value of $8.5M. Key products include Dolutegravir ($113K), Sodium ($113K), Acetylsalicylic ($64K), Dexamethasone ($54K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,494 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Gambia Trade Routes

1Dolutegravir$113K

2Sodium$113K

3Acetylsalicylic$64K

4Dexamethasone$54K

These are the top pharmaceutical products exported from India to Gambia, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Gambia buyers, regulatory requirements, and logistics for that specific product corridor. Products include Dolutegravir ($113K), Sodium ($113K), ($64K), — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Gambia

1Kgn Pharmaceuticals Private Limited

$1.2M

2Syncom Formulations (india) Limited

$973K

3Medinomics Health Care Private Limited

$766K

4Savorite Pharmaceuticals Private Limited

$638K

5Quicklab Services

Port Analysis — India to Gambia Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)23.7%

JNPT/ NHAVA SHEVA SEA7.3%

JNPT8.0%

CHENNAI AIR1.5%

NHAVA SHEVA6.6%

Gambia Import Ports

Banjul44.6%

BANJUL51.8%

Dakar0.7%

Trade Statistics

Total Value$8.5M

Shipments1,494

Indian Exporters58

Gambia Buyers66

Avg Shipment$6K

Products1,060

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Gambia Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and The Gambia has experienced significant growth from 2022 to 2026. In 2022, the total export value was approximately $2.5 million USD, with 300 shipments from 20 Indian exporters to 30 Gambian buyers. By 2026, these figures escalated to a total export value of $8.5 million USD, encompassing 1,494 shipments from 58 Indian exporters to 66 Gambian buyers. This growth trajectory underscores the strengthening bilateral trade relations and India's expanding footprint in The Gambia's pharmaceutical market.

2India's Market Position

India has solidified its position as a primary supplier of pharmaceutical products to The Gambia. In 2024, Gambia's total pharmaceutical imports were valued at $49.8 million USD, with Indian exports accounting for approximately $3.07 million USD. This indicates that Indian pharmaceutical products constitute about 6% of The Gambia's total pharmaceutical imports, highlighting India's strategic importance in meeting the country's healthcare needs.

3Recent Developments

In June 2023, the Medicines Control Agency (MCA) of The Gambia mandated pre-shipment inspection and quality control testing for all pharmaceutical products imported from India. Effective July 1, 2023, these regulations require Indian pharmaceutical shipments to undergo document verification, physical inspection, and quality control testing, culminating in the issuance of a Clean Report of Inspection and Analysis (CRIA). This initiative aims to ensure the quality and safety of imported medicines, addressing concerns over substandard and counterfeit products.

Gambia Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in The Gambia must adhere to the guidelines set forth by the MCA. Applications require submission of a completed application form, a drug master file (DMF) where necessary, and manufacturing licenses along with Good Manufacturing Practice (GMP) certificates from the country of origin. The MCA stipulates that all product registration application dossiers be submitted in Common Technical Document (CTD) format, both in hard and soft copies. This structured approach ensures that all pharmaceutical products meet the regulatory standards for safety and efficacy. (mca.gm)

2GMP & Facility Requirements

The Gambia requires that pharmaceutical products imported from India be manufactured in facilities compliant with WHO-GMP standards. The MCA conducts inspections to verify compliance with these standards before granting licenses for commercial production. This process is part of The Gambia's broader initiative to enhance the national regulator’s ability to effectively monitor the pharmaceutical market, ensuring that all imported medicines are of high quality and safe for public use.

3Import Documentation

To import pharmaceutical products into The Gambia, Indian exporters must provide several key documents:

Import Declaration Form: Prepared in triplicate and submitted to Customs.

Invoice: Detailing cost, insurance, and freight.

Bill of Lading or Air Waybill: Proof of shipment.

Certificate of Origin: Indicating the product's origin, applicable under WTO rates.

Packing Lists: Detailed descriptions of the contents.

Licenses and Certificates: As required by law, including GMP certificates.

Tax Identification Number (TIN): For customs processing.

These documents facilitate the clearance of goods through customs and ensure compliance with The Gambia's import regulations.

TransData Nexus Research · Gambia regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Gambia

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

The dominant categories in India's pharmaceutical exports to The Gambia include antimalarial drugs, antiretrovirals, and diagnostic test kits. These products align with The Gambia's healthcare priorities, addressing prevalent diseases such as malaria and HIV/AIDS. The substantial export of antimalarial drugs, including combinations like Amodiaquine and Sulfadoxine/Pyrimethamine, reflects the country's ongoing efforts to combat malaria. Similarly, the export of antiretrovirals such as Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate tablets supports The Gambia's HIV/AIDS treatment programs. Diagnostic test kits, including CRP and HbA1c test kits, are essential for disease monitoring and management, further underscoring the alignment of India's exports with The Gambia's healthcare needs.

2Emerging Opportunities

The expiration of patents for several branded pharmaceutical products presents opportunities for Indian exporters to introduce generic versions into The Gambia's market. Additionally, the growing demand for biosimilars offers a potential avenue for expansion. Indian pharmaceutical companies can leverage their expertise in these areas to meet the evolving healthcare demands of The Gambia, particularly in the treatment of chronic diseases and conditions requiring specialized therapies.

3Demand Drivers

The Gambia's disease burden, characterized by high incidences of malaria, HIV/AIDS, and other infectious diseases, drives the demand for pharmaceutical imports. The aging population and increasing prevalence of non-communicable diseases further contribute to this demand. Healthcare spending trends indicate a growing investment in health infrastructure and services, creating a favorable environment for pharmaceutical imports. These factors collectively enhance the market potential for Indian pharmaceutical products in The Gambia.

TransData Nexus Research · DGFT trade data analysisMar 2026

FAQ — India to Gambia Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Gambia?

India exported pharmaceuticals worth $8.5M to Gambia across 1,494 verified shipments.

Who are the top Indian pharmaceutical exporters to Gambia?

1. KGN PHARMACEUTICALS PRIVATE LIMITED — $1.2M. 2. SYNCOM FORMULATIONS (INDIA) LIMITED — $972.6K. 3. MEDINOMICS HEALTH CARE PRIVATE LIMITED — $765.9K. Total: 58 suppliers.

Which companies in Gambia import pharmaceuticals from India?

1. KAIRABA PHARMACEUTICALS LTD — $1.4M. 2. CITY PHARMACY — $1.2M. 3. MEDICARE CLINIC — $578.0K. 66 buyers total.

What pharmaceutical products does India export most to Gambia?

1. Crp Test Kit ($386.7K, 4.6%); 2. Dolutegravir(as Sodium)/lamivudine/tenofovir Disoproxil Fumaratetabletsa#a#a# 5… ($317.0K, 3.7%); 3. Harmless Medicines:amodiaquine 150mg +sulfadoxine/pyrimethamine 500/25mg Disper… ($152.3K, 1.8%); 4. Hba1c Test Kit ($85.8K, 1.0%); 5. Dolutegravir (as Sodium)+lamivudine+tenofovir Disoproxil Fumarate Tablets 50/30… ($79.9K, 0.9%)

Which ports handle pharmaceutical shipments from India to Gambia?

Export: NHAVA SHEVA SEA (INNSA1), JNPT/ NHAVA SHEVA SEA, JNPT, CHENNAI AIR, NHAVA SHEVA. Import: Banjul, BANJUL, Dakar.

Why does Gambia import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $8.5M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Gambia?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Gambia pharmaceutical trade?

$5.7K per consignment across 1,494 shipments.

How many Indian pharmaceutical companies export to Gambia?

58 Indian companies. Largest: KGN PHARMACEUTICALS PRIVATE LIMITED with $1.2M.

How can I find verified Indian pharmaceutical suppliers for Gambia?

TransData Nexus covers 58 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Gambia identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1,494 verified shipments from 58 Indian exporters to 66 Gambia buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

58 Exporters

66 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Gambia Pharmaceutical Export

Top Pharmaceutical Formulations — India to Gambia

Top Pharmaceutical Products — India to Gambia Trade Routes

Top Indian Exporters to Gambia

Port Analysis — India to Gambia Pharmaceutical Shipments

Indian Export Ports

Gambia Import Ports

Trade Statistics

Other Destinations

India–Gambia Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

3Recent Developments

Top Gambia Buyers from India

Product Routes

Full Dataset Access

Gambia Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Gambia

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Gambia

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Gambia Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Gambia for Indian Pharma

1Market Size & Growth

2Healthcare System